ALYFTREK
Live / Registered — Registered (as of 29 Jul 2025)
What this means for you
Registered since 29 Jul 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98321063
- Registration number
- 7875259
- Mark type
- Stylized text
- Filed
- 19 Dec 2023
- Published for opposition
- 07 May 2024
- Registered
- 29 Jul 2025
- Attorney of record
- Kelli A. Ovies
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cystic fibrosis
Owner
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
Prosecution history
- 29 Jul 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 29 Jul 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Jul 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Apr 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Feb 2025 — USE AMENDMENT FILED
- 10 Feb 2025 — TEAS STATEMENT OF USE RECEIVED
- 09 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Apr 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Dec 2024 — SOU EXTENSION 1 GRANTED
- 09 Dec 2024 — SOU EXTENSION 1 FILED
- 09 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 02 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 May 2024 — PUBLISHED FOR OPPOSITION
- 07 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED